2020-2022 State Health Improvement Plan
Ohio Department of Health, 2020
Recommendations to prevent drug dependence/abuse and overdose deaths based on a review of research evidence and input from Ohio stakeholders.
This resource page is part of the HPIO Addiction Evidence Project and covers topics relevant to three components of the comprehensive policy response to addiction framework: Prevention, treatment and recovery. Click here to view other phases of the Addiction Evidence Project.
Recommendations to prevent drug dependence/abuse and overdose deaths based on a review of research evidence and input from Ohio stakeholders.
National report that supports health care providers, systems and communities seeking to prevent substance misuse among young adults. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges and offers useful resources.
Report that contains evidence-based interventions to inform and guide college officials on creating strategies to reduce underage drinking and alcohol-related harm on campuses.
Recommendations for clinicians, developed by an independent expert panel, on appropriate and effective use of screening and brief counseling to reduce alcohol misuse among adults and adolescents.
Report that includes list of evidence-based and promising policies and programs prevent excessive drinking (see Section 4 and Appendix A).
Recommendations related to screening and treating alcohol abuse in adolescents.
Systematic reviews of community preventive services, including strategies to prevent excessive alcohol consumption and tobacco use.
Summarizes the current state of evidence regarding what is known about the health impacts of cannabis and cannabis-derived products, including effects related to therapeutic uses of cannabis and potential health risks related to certain cancers, diseases, mental health disorders, and injuries.
See also: HPIO medical marijuana resource page
A tool to help identify evidence-based youth marijuana prevention programs to implement in one’s community.
Recommendations related to marijuana legalization and use in the child and adolescent populations.
Sample policy created by a consortium of national public health organizations to guide state and local jurisdictions on the development of policies to increase the minimum legal sales age for tobacco products. Addresses licensing, definitions, enforcement and other topics.
Policy statement that sets forth strategies to keep future generations from initiating the use of tobacco.
Consensus study report that summarizes the current state of evidence regarding what is known about health effects, initiation and cessation of combustible tobacco cigarette use and harm reduction.
Fact sheet that identifies four policy options to reduce tobacco use and secondhand smoke exposure based upon availability of strong evidence of effectiveness and relevance to Ohio’s state policy landscape.
Technical assistance developed by the Tobacco Control Legal Consortium to advise jurisdictions on the policy implications of changes to the minimum legal sales age for tobacco products.
Searchable database that rates the strength of evidence of effectiveness (strong, moderate, suggestive) for a wide range of clinical health care innovations.
Systematic reviews of community preventive services, including strategies to prevent excessive alcohol consumption and tobacco use.
Searchable compendium of interventions, focused primarily on chronic disease prevention, including tobacco prevention and cessation. (Does not specifically address addiction to other drugs.)
An overview of the evidence of effectiveness for contingency management to improve outcomes for people with a substance use disorder.
Recommendations to reduce drug dependence/abuse and overdose deaths, including strategies to improve behavioral health access, system quality and workforce, based on a review of research evidence and input from Ohio stakeholders.
An issue brief discussing the barriers to treatment for opioid use disorder, the evidence supporting a “low-threshold” approach for MAT and areas for future research.
Concise guide for physicians on best practices for use of Buprenorphine for the treatment of opioid use disorder.
Updated guidance for clinicians, developed by an independent committee of experts, on the appropriate and effective use of medications (methadone, buprenorphine/Suboxone, naltrexone/Vivitrol) and psychosocial methods to evaluate and treat opioid use disorder and opioid overdose.
Expert consensus statement on the effectiveness of medication-based treatment for opioid use disorder, included best treatment practices in different care settings and best practices for treating different populations, such as pregnant women, racial and ethnic minority populations, and individuals with comorbidities.
An academic article reporting attendance and substance use outcomes for contingency management programs at the Department of Veterans Affairs compared to outcomes in controlled clinical trials.
Recommendations for a public health response to opiate use and abuse in pregnancy.
Guidance for clinicians about the effective use of drug testing in the identification, diagnosis, treatment and promotion of recovery for patients with, or at risk for, addiction.
This committee opinion is a resource for clinicians in obstetrics and gynecology related to opioid screening and prescribing.
Systematic review reporting on the effectiveness of opioid substitution treatment (methadone and buprenorphine) at reducing the risk of all cause and overdose mortality.
Recommendations for MAT of adolescents with opioid use disorders.
Describes Medicaid pharmacy benefit management strategies for mitigating prescription drug abuse, such as provider education, preferred drug lists, clinical criteria, prior authorization, quantity limits and increased use of Prescription Drug Monitoring Programs (PDMPs). Also addresses strategies state Medicaid programs can take to increase provision of naloxone for overdose reversal and access to opioid use disorder treatment.
Guidance for clinicians, developed by a consensus panel, on the appropriate and effective use of injectable naltrexone (Vivitrol).
Description of minimum acceptable standards for opioid treatment programs (OTPs)—treatment providers that administer methadone and/or buprenorphine (Suboxone)—developed by a panel of experts.
Comprehensive set of guidelines for placement, continued stay and transfer/discharge of patients with addiction and co-occurring conditions. Designed for addiction treatment providers serving adolescents and adults.
Detailed best-practice guidelines, developed by a consensus panel, to inform Opioid Treatment Programs (OTPs)—treatment providers that administer methadone, buprenorphine (Suboxone), LAAM or naltrexone (Vivitrol).
Detailed best-practice guidelines, developed by a consensus panel, to inform use of buprenorphine in opioid addiction treatment.
Clinical practice guideline on alcohol withdrawal management.
Guidance for clinicians based on a review of the research evidence. Includes specific recommendations on Medication-Assisted Treatment (MAT) and nonpharmacological therapies for patients who are seeking to reduce their alcohol consumption or achieve abstinence.
Report providing evidence for two off-shoots of the community reinforcement approach for adolescents and treatment-refusing individuals and their families.
Recommendations related to screening and treating alcohol abuse in adolescents.
A practice manual for clinicians to implement alcohol screening and brief intervention into their practices.
SAMHSA guide on evidence-based treatment for stimulant use disorders, including guidance on selecting and implementing evidence-based treatment practices.
Systematic review reporting on the efficacy of psychosocial interventions to treat cocaine and/or amphetamine use to inform patients, clinicians and policymakers decision-making on interventions.
Research report which includes summary of effective approaches to cocaine addiction treatment.
Research report which includes summary of effective approaches to methamphetamine addiction treatment.
Guidance for substance use disorder treatment providers on appropriate treatment of stimulant abuse and dependence, including addiction to cocaine and methamphetamine.
Recommendations for primary care clinicians, developed by an independent expert panel, on appropriate and effective use of education and brief counseling for tobacco cessation (nicotine addiction treatment) for children and adolescents.
Expert consensus statement that provides a comprehensive approach for healthcare providers to evaluate and treat tobacco dependence.
Consensus study report that summarizes the current state of evidence regarding what is known about health effects, initiation and cessation of combustible tobacco cigarette use and harm reduction.
Fact sheet that identifies four policy options to reduce tobacco use and secondhand smoke exposure based upon availability of strong evidence of effectiveness and relevance to Ohio’s state policy landscape.
Recommendations for clinicians, developed by an independent expert panel, on appropriate and effective use of screening, behavioral counseling and FDA-approved medications for tobacco cessation for adults.
Explains epidemiology of tobacco use and health consequences. Presents strategies for promoting tobacco cessation and explains the health benefits of tobacco cessation.
Searchable database that rates the strength of evidence of effectiveness (strong, moderate, suggestive) for a wide range of clinical health care innovations.
Searchable compendium of interventions, focused primarily on chronic disease prevention, including tobacco prevention and cessation. (Does not specifically address addiction to other drugs.)
Evidence summaries for clinical prevention and treatment interventions to address high-burden health conditions, including tobacco use. (Does not specifically address addiction to other drugs.)
A checklist of specific measures to be used by recovery residences (recovery housing) related to the administration of the residence and creating a supportive environment for recovery.
Code of ethics for recovery residence (recovery housing) owners, operators, staff and volunteers.
A checklist of specific measures to be used by recovery residences (recovery housing) related to the administration of the residence and creating a supportive environment for recovery.
Code of ethics for recovery residence (recovery housing) owners, operators, staff and volunteers.
Summarizes research findings on the effectiveness of approaches used by mutual aid groups (such as 12-step groups) and recovery support services (such as peer recovery coaching, recovery housing).
Description of models of peer recovery support services.
Description of models of peer recovery support services.
Description of models of peer recovery support services.
Best practice guidelines regarding vocational services to increase employment among substance abuse treatment clients.
Searchable database of systematic reviews on wide range of healthcare topics, including a “Tobacco, drugs and alcohol” category.
This resource page provides links to three types of credible guidance on what works to address addiction:
HPIO invites your feedback in improving our work and assessing our effectiveness. Please take a few minutes to fill out this 11-question stakeholder survey.
Take stakeholder survey